UniProt ID | CBX6_HUMAN | |
---|---|---|
UniProt AC | O95503 | |
Protein Name | Chromobox protein homolog 6 | |
Gene Name | CBX6 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 412 | |
Subcellular Localization | Nucleus . Chromosome . Uniformely distributed in the nucleoplasm (PubMed:18927235). Localizes to the inactivated X chromosome in females (By similarity). | |
Protein Description | Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. [PubMed: 21282530 PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility. Possibly contributes to the target selectivity of the PRC1 complex by binding specific regions of chromatin] | |
Protein Sequence | MELSAVGERVFAAESIIKRRIRKGRIEYLVKWKGWAIKYSTWEPEENILDSRLIAAFEQKERERELYGPKKRGPKPKTFLLKARAQAEALRISDVHFSVKPSASASSPKLHSSAAVHRLKKDIRRCHRMSRRPLPRPDPQGGSPGLRPPISPFSETVRIINRKVKPREPKRNRIILNLKVIDKGAGGGGAGQGAGALARPKVPSRNRVIGKSKKFSESVLRTQIRHMKFGAFALYKPPPAPLVAPSPGKAEASAPGPGLLLAAPAAPYDARSSGSSGCPSPTPQSSDPDDTPPKLLPETVSPSAPSWREPEVLDLSLPPESAATSKRAPPEVTAAAGPAPPTAPEPAGASSEPEAGDWRPEMSPCSNVVVTDVTSNLLTVTIKEFCNPEDFEKVAAGVAGAAGGGGSIGASK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MELSAVGERVF ----CCCCCHHHHHH | 13.96 | 19007248 | |
15 | Phosphorylation | ERVFAAESIIKRRIR HHHHHHHHHHHHHHH | 25.53 | 24719451 | |
18 | Ubiquitination | FAAESIIKRRIRKGR HHHHHHHHHHHHCCC | 33.67 | 21890473 | |
33 | Ubiquitination | IEYLVKWKGWAIKYS CEEEEEECCEEEEEC | 38.57 | 21890473 | |
38 | Ubiquitination | KWKGWAIKYSTWEPE EECCEEEEECCCCCC | 25.96 | 21890473 | |
39 | Phosphorylation | WKGWAIKYSTWEPEE ECCEEEEECCCCCCH | 12.76 | 20068231 | |
40 | Phosphorylation | KGWAIKYSTWEPEEN CCEEEEECCCCCCHH | 23.26 | 20068231 | |
41 | Phosphorylation | GWAIKYSTWEPEENI CEEEEECCCCCCHHC | 30.66 | 20068231 | |
51 | Phosphorylation | PEENILDSRLIAAFE CCHHCCCHHHHHHHH | 26.07 | 20068231 | |
60 | Ubiquitination | LIAAFEQKERERELY HHHHHHHHHHHHHHH | 52.09 | - | |
82 | Ubiquitination | KPKTFLLKARAQAEA CCCCCHHHHHHHHHH | 37.66 | 21890473 | |
93 | Phosphorylation | QAEALRISDVHFSVK HHHHHEECEEEEECC | 27.44 | 23186163 | |
98 | Phosphorylation | RISDVHFSVKPSASA EECEEEEECCCCCCC | 17.85 | 23186163 | |
100 | Ubiquitination | SDVHFSVKPSASASS CEEEEECCCCCCCCC | 31.86 | 21890473 | |
100 | Acetylation | SDVHFSVKPSASASS CEEEEECCCCCCCCC | 31.86 | 12656479 | |
102 | Phosphorylation | VHFSVKPSASASSPK EEEECCCCCCCCCCC | 29.19 | 23403867 | |
104 | Phosphorylation | FSVKPSASASSPKLH EECCCCCCCCCCCCC | 32.78 | 21712546 | |
106 | Phosphorylation | VKPSASASSPKLHSS CCCCCCCCCCCCCCH | 44.68 | 22617229 | |
107 | Phosphorylation | KPSASASSPKLHSSA CCCCCCCCCCCCCHH | 26.27 | 23911959 | |
112 | Phosphorylation | ASSPKLHSSAAVHRL CCCCCCCCHHHHHHH | 31.91 | 23312004 | |
113 | Phosphorylation | SSPKLHSSAAVHRLK CCCCCCCHHHHHHHH | 14.97 | 23403867 | |
130 | Phosphorylation | IRRCHRMSRRPLPRP HHHHHHHHCCCCCCC | 25.70 | 27251275 | |
143 | Phosphorylation | RPDPQGGSPGLRPPI CCCCCCCCCCCCCCC | 23.71 | 28985074 | |
151 | Phosphorylation | PGLRPPISPFSETVR CCCCCCCCCCHHHHH | 26.18 | 21712546 | |
154 | Phosphorylation | RPPISPFSETVRIIN CCCCCCCHHHHHHHC | 35.42 | 23312004 | |
156 | Phosphorylation | PISPFSETVRIINRK CCCCCHHHHHHHCCC | 17.56 | 23312004 | |
179 | Ubiquitination | NRIILNLKVIDKGAG CCEEEEEEEEECCCC | 35.75 | - | |
183 | Ubiquitination | LNLKVIDKGAGGGGA EEEEEEECCCCCCCC | 39.27 | - | |
204 | Phosphorylation | LARPKVPSRNRVIGK CCCCCCCCCCCCCCC | 45.21 | 20068231 | |
214 | Ubiquitination | RVIGKSKKFSESVLR CCCCCCHHCCHHHHH | 62.30 | - | |
236 | Ubiquitination | FGAFALYKPPPAPLV CCEEEEECCCCCCEE | 52.47 | - | |
246 | Phosphorylation | PAPLVAPSPGKAEAS CCCEECCCCCCCCCC | 36.23 | 22617229 | |
253 | Phosphorylation | SPGKAEASAPGPGLL CCCCCCCCCCCCCEE | 26.88 | 22210691 | |
272 | Phosphorylation | AAPYDARSSGSSGCP CCCCCCCCCCCCCCC | 40.55 | 28450419 | |
273 | Phosphorylation | APYDARSSGSSGCPS CCCCCCCCCCCCCCC | 36.82 | 21815630 | |
275 | Phosphorylation | YDARSSGSSGCPSPT CCCCCCCCCCCCCCC | 26.04 | 28450419 | |
276 | Phosphorylation | DARSSGSSGCPSPTP CCCCCCCCCCCCCCC | 48.19 | 21815630 | |
280 | Phosphorylation | SGSSGCPSPTPQSSD CCCCCCCCCCCCCCC | 45.54 | 25159151 | |
282 | Phosphorylation | SSGCPSPTPQSSDPD CCCCCCCCCCCCCCC | 37.99 | 25159151 | |
285 | Phosphorylation | CPSPTPQSSDPDDTP CCCCCCCCCCCCCCC | 37.60 | 28450419 | |
286 | Phosphorylation | PSPTPQSSDPDDTPP CCCCCCCCCCCCCCC | 48.17 | 30108239 | |
291 | Phosphorylation | QSSDPDDTPPKLLPE CCCCCCCCCCCCCCC | 49.20 | 25002506 | |
299 | Phosphorylation | PPKLLPETVSPSAPS CCCCCCCCCCCCCCC | 25.09 | 30266825 | |
301 | Phosphorylation | KLLPETVSPSAPSWR CCCCCCCCCCCCCCC | 22.13 | 30266825 | |
303 | Phosphorylation | LPETVSPSAPSWREP CCCCCCCCCCCCCCC | 45.35 | 30266825 | |
306 | Phosphorylation | TVSPSAPSWREPEVL CCCCCCCCCCCCCCC | 38.18 | 30108239 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CBX6_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CBX6_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CBX6_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-280, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-301 AND SER-303, ANDMASS SPECTROMETRY. |